These data indicate that ICAM-1–FGG axis sustains cell survival-related ERK and Akt signaling but restrains apoptosis-related JNK and p38 pathways, thus protects NSCLC cells from apoptosis. This evidence concerns the gene MAPK1 and non-small cell lung carcinoma.